financetom
Business
financetom
/
Business
/
PhonePe hits 250 mn user mark, registers 925 mn transactions in October
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
PhonePe hits 250 mn user mark, registers 925 mn transactions in October
Nov 2, 2020 4:28 AM

Flipkart-owned fintech platform PhonePe on Monday said it has crossed the 250 million registered user milestone. The company reported over 100 million monthly active users (MAU) and 2.3 billion app sessions in October, a statement said. ”PhonePe had a record month in October, processing 925 million transactions – its highest so far – with an annual TPV (total payment volume) run rate of USD 277 billion. PhonePe also processed 835 million UPI transactions in October, for a market-leading share of over 40 percent,” it added.

Sameer Nigam, CEO and founder of PhonePe, said the company has set a target of crossing 500 million registered users by December 2022. ”In line with our brand ethos of ’Karte Ja. Badhte Ja’, we continue to launch new and innovative products for every strata of Indian society, as well as enable digital payment acceptance across every merchant in every village and town in India,” he added.

PhonePe – which competes with the likes of Paytm, MobiKwik and Google Pay – allows users to send and receive money, recharge mobile and make utility payments as well as buy gold and make investments. It had also launched its ’Switch’ platform that allows customers can place orders on over 220 apps including Ola, Myntra, IRCTC, Goibibo, RedBus and Oyo.

Also Read

: Paytm Postpaid aims to double postpaid service users to 1.5 cr by March 2021

PhonePe is accepted at 13 million merchant outlets across 500 cities nationally.

First Published:Nov 2, 2020 1:28 PM IST

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
CleanCore Solutions Congratulates House of Doge on Successful Go-Public Transaction and Provides Treasury Update
CleanCore Solutions Congratulates House of Doge on Successful Go-Public Transaction and Provides Treasury Update
Oct 13, 2025
In collaboration with House of Doge and its strategic partners 21Shares and Robinhood, CleanCore will gain access to alpha-generating yield strategies designed to enhance treasury performance and long-term asset growth. House of Doge aims to accelerate Dogecoin’s adoption and real-world utility across commerce and paymentsHouse of Doge starts real-world tokenization initiatives, further accelerating the demand for dogecoin        ...
Bicara Therapeutics Says Potential Head, Neck Cancer Drug Gets FDA Breakthrough Therapy Designation
Bicara Therapeutics Says Potential Head, Neck Cancer Drug Gets FDA Breakthrough Therapy Designation
Oct 13, 2025
08:30 AM EDT, 10/13/2025 (MT Newswires) -- Bicara Therapeutics ( BCAX ) said Monday that ficerafusp alfa in combination with pembrolizumab for the treatment of head and neck squamous cell carcinoma, or HNSCC, has received Breakthrough Therapy Designation from the US Food and Drug Administration. The designation shows recognition of human papillomavirus-negative HNSCC as a clear clinical indication within head...
Blackboxstocks Inc. Announces its Merger Target REalloys inks LOI for a 10-Year Offtake Agreement for 15% of Tanbreez Production with Critical Metals Corp. to Strengthen North American Rare Earth Inde
Blackboxstocks Inc. Announces its Merger Target REalloys inks LOI for a 10-Year Offtake Agreement for 15% of Tanbreez Production with Critical Metals Corp. to Strengthen North American Rare Earth Inde
Oct 13, 2025
The LOI is for a 10-year off-take agreement, which plans to provide REalloys with long-term heavy rare earth feedstock from Critical Metals Corp.’s Tanbreez Project in Greenland, one of the world’s most significant deposits. REalloys’ strategic partnership aligns with U.S. and allied priorities to build a fully independent North American mine-to-magnet supply chain. NEW YORK, Oct. 13, 2025 (GLOBE NEWSWIRE)...
Moderna Says Investigational Cancer Antigen Therapy Shows 'Promising' Early Data
Moderna Says Investigational Cancer Antigen Therapy Shows 'Promising' Early Data
Oct 13, 2025
08:30 AM EDT, 10/13/2025 (MT Newswires) -- Moderna ( MRNA ) said Monday that its investigational cancer antigen therapy, mRNA-4359, in combination with pembrolizumab, has shown promising results in its phase 1/2 trial in certain Melanoma patients. The company said the combination therapy achieved a 24% objective response rate and a 60% disease control rate. Among a subgroup of patients...
Copyright 2023-2026 - www.financetom.com All Rights Reserved